Sign In
Buy ETON
$27.61
+0.210 (+0.766%)
At Close: Jun 03, 2026
Best Penny Stocks To Buy? 4 To Watch In January 2023
08:51am, Wednesday, 11'th Jan 2023
4 Biotech Penny Stocks To Watch, January 2023 The post Best Penny Stocks To Buy? 4 To Watch In January 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Eton Pharmaceuticals: Alkindi Sprinkle Leads Growth In Orphan Disease Portfolio
06:00am, Sunday, 18'th Dec 2022
Shares have lost 25% of their value in 2023. Alkindi Sprinkle is their lead orphan product, addressing a $100M opportunity and providing a low-dose option of hydrocortisone treatment.
Eton Pharmaceuticals, Inc. (ETON) Q3 2022 Earnings Call Transcript
08:08pm, Thursday, 10'th Nov 2022
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants David Krempa - Senior Vice President, Business Development & Investor Relat
Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022
04:05pm, Wednesday, 02'nd Nov 2022
DEER PARK, Ill., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare disease
Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference
06:50am, Tuesday, 18'th Oct 2022
DEER PARK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2022 Results - Earnings Call Transcript
04:27am, Friday, 12'th Aug 2022
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants David Krempa - Senior Vice President of Business Development & Investor Relat
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Misses Revenue Estimates
06:49pm, Thursday, 11'th Aug 2022
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -300% and 5.30%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock
Eton Pharmaceuticals (ETON) Stock Is Up 10% on FDA Approval
11:44am, Monday, 18'th Jul 2022
Eton Pharmaceuticals (ETON) stock is on the rise Monday as investors react to news of approval from the FDA for Zonisade. The post Eton Pharmaceuticals (ETON) Stock Is Up 10% on FDA Approval appeared
Why Eton Pharmaceuticals Stock Is Moving Higher
10:59am, Monday, 18'th Jul 2022
Eton Pharmaceuticals Inc (NASDAQ: ETON) shares are trading higher Monday after the company announced FDA approval of ZONISADE. ZONISADE was included in Eton's multi-product partnership with Azurit
Eton's stock gains 16% after announcing FDA approval of epilepsy drug
08:09am, Monday, 18'th Jul 2022
Shares of Eton Pharmaceuticals Inc. ETON, +3.33% jumped 16.5% in premarket trading on Monday after the company said the Food and Drug Administration approved Zonisade, a seizure treatment for adults a
Eton Pharma Shares Tick Higher After Offloading Hospital Products
09:51am, Friday, 24'th Jun 2022
Eton Pharmaceuticals Inc (NASDAQ: ETON) has sold its hospital products to Dr. Reddy's Laboratories SA, a subsidiary of Dr. Reddy's Laboratories Ltd (NYSE: RDY), for $50 million. "The sale of our
Eton Pharmaceuticals, Inc. (ETON) Reports Q1 Loss, Lags Revenue Estimates
06:48pm, Thursday, 12'th May 2022
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of -162.50% and 69.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the
Eton Pharmaceuticals, Inc.'s (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call Transcript
06:30pm, Thursday, 12'th May 2022
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants David Krempa – Senior Vice President-Business Development and Investor Relatio
Analysts Estimate Eton Pharmaceuticals, Inc. (ETON) to Report a Decline in Earnings: What to Look Out for
04:33pm, Thursday, 05'th May 2022
Eton Pharmaceuticals, Inc. (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2021 Results - Earnings Call Transcript
10:50pm, Wednesday, 16'th Mar 2022
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2021 Results - Earnings Call Transcript
